Otsuka Pakistan Limited (OTSU) will suspend its production operations from December 20, 2025, to January 4, 2026, to carry out scheduled annual preventive maintenance.
The company confirmed that manufacturing activities will resume on January 5, 2026.
The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.
About the Author
Written by the expert legal team at Javid Law Associates. Our team specializes in corporate law, tax compliance, and business registration services across Pakistan.
Verified Professional
25+ Years Experience